Protocol details methods to differentiate endothelial cells from iPSCs, suggesting improved cell treatments for vascular malformations.
Vascular malformations caused by genetic PI3K pathway activation are highly debilitating and hard to treat. Here, we present a PI3K inhibitor-free protocol to differentiate arterial and venous endothelial cells from human induced pluripotent stem cells (iPSCs) in 2D and 3D formats. We describe steps for iPSC culture, cell seeding on a synthetic matrix, defined media preparation, magnetic-activated cell sorting, and endothelial cell maturation under shear stress. We then detail procedures for determining cell density and culture duration for robust functional phenotyping.
No takes yet. Share an insight, caveat, or question.
Mruk et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: